XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Nature of Operations and Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 07, 2024
May 07, 2024
Feb. 15, 2022
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Jun. 06, 2024
Product Information [Line Items]                  
Proceeds from issuance of common stock     $ 21,711,000            
Reverse stock split, description   one-for-twelve              
Issuance of common stock shares issued 107,126                
Common stock, shares issued 791,580     791,580   791,580   673,090  
Common stock, shares outstanding 791,580     791,580   791,580   673,090  
FDIC insured amount       $ 250,000   $ 250,000      
Cash balance, amount       11,325,387   11,325,387   $ 12,508,251  
FDIC uninsured amount       11,075,000   11,075,000      
Allowance for doubtful accounts receivable           89,000   125,000  
Provision for doubtful accounts           $ (36,489) $ 2,096    
Potentially dilutive equity instruments that are convertible into common stock           661,434 667,490    
Contract assets       224,414   $ 224,414   224,414  
Allowance for doubtful accounts       1,436   1,436   1,436  
Contract with customer liability current       393,358   393,358   499,800  
Revenue recognized       69,170 $ 45,716 116,610 $ 3,898,622    
Revenue remaining performance obligation       227,000 $ 1,066,000 $ 227,000 $ 1,066,000    
Contract revenue       1,200,000          
Product warranty description           The Company assesses the historical warranty claims on its manufactured products and, since 2016, warranty claims have been approximately 1% of annual revenue generated on these products. Based on the Company’s warranty policy, an accrual is established at 1% of the trailing 18 months revenue.      
Product Warranty Accrual, Current       $ 103,168   $ 103,168   $ 191,338  
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer One [Member]                  
Product Information [Line Items]                  
Concentration risk percentage       72.00% 64.00% 64.00% 44.00%    
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Two [Member]                  
Product Information [Line Items]                  
Concentration risk percentage       11.00% 10.00% 10.00% 23.00%    
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer Three [Member]                  
Product Information [Line Items]                  
Concentration risk percentage             14.00%    
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member]                  
Product Information [Line Items]                  
Concentration risk percentage           49.00%   59.00%  
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Two [Member]                  
Product Information [Line Items]                  
Concentration risk percentage           38.00%   29.00%  
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Three [Member]                  
Product Information [Line Items]                  
Concentration risk percentage           13.00%   12.00%  
Maximum [Member]                  
Product Information [Line Items]                  
Revenue remaining performance obligation       $ 839,000   $ 839,000      
Director And Staff [Member]                  
Product Information [Line Items]                  
Potentially dilutive equity instruments that are convertible into common stock           26,120 32,176    
Series B Preferred Stock [Member]                  
Product Information [Line Items]                  
Potentially dilutive equity instruments that are convertible into common stock           635,314 635,314    
Reverse Stock Split [Member]                  
Product Information [Line Items]                  
Common stock, shares issued                 8,076,372
Common stock, shares outstanding                 8,076,372